 | • レポートコード：QYR9NV06357 • 出版社/出版日：QYResearch / 2019年11月12日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア |
| Single User | ￥525,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,050,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、ヒト血漿由来治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アルブミン、免疫グロブリン、凝固因子、プロトロンビン複合体、その他に、用途別には、病院、診療所、研究センターにセグメント区分し、ヒト血漿由来治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ヒト血漿由来治療薬の世界市場概要 ・ヒト血漿由来治療薬の製造コスト構成分析 ・ヒト血漿由来治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ヒト血漿由来治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ヒト血漿由来治療薬のセグメント分析（種類別） （アルブミン、免疫グロブリン、凝固因子、プロトロンビン複合体、その他） ・ヒト血漿由来治療薬のセグメント分析（用途別） （病院、診療所、研究センター） ・ヒト血漿由来治療薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Alkahest、Baxter、CSL Behring、Entegrion, Inc.、Gammagard、Grifols、Kedrion、Octapharma、Prometic Life Sciences、Sanquin、Shire、） ・ヒト血漿由来治療薬の市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global Human Plasma-Derived Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Human Plasma-Derived Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Human Plasma-Derived Therapeutics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Human Plasma-Derived Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Human Plasma-Derived Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Alkahest
Baxter
CSL Behring
Entegrion, Inc.
Gammagard
Grifols
Kedrion
Octapharma
Prometic Life Sciences
Sanquin
Shire
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Albumin
Immunoglobulin
Clotting Factor
Prothrombin Complex
Others
Segment by Application
Hospital
Clinic
Research Center
Table of Contents
Executive Summary
1 Industry Overview of Human Plasma-Derived Therapeutics
1.1 Definition of Human Plasma-Derived Therapeutics
1.2 Human Plasma-Derived Therapeutics Segment by Type
1.2.1 Global Human Plasma-Derived Therapeutics Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Albumin
1.2.3 Immunoglobulin
1.2.4 Clotting Factor
1.2.5 Prothrombin Complex
1.2.6 Others
1.3 Human Plasma-Derived Therapeutics Segment by Applications
1.3.1 Global Human Plasma-Derived Therapeutics Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Center
1.4 Global Human Plasma-Derived Therapeutics Overall Market
1.4.1 Global Human Plasma-Derived Therapeutics Revenue (2014-2025)
1.4.2 Global Human Plasma-Derived Therapeutics Production (2014-2025)
1.4.3 North America Human Plasma-Derived Therapeutics Status and Prospect (2014-2025)
1.4.4 Europe Human Plasma-Derived Therapeutics Status and Prospect (2014-2025)
1.4.5 China Human Plasma-Derived Therapeutics Status and Prospect (2014-2025)
1.4.6 Japan Human Plasma-Derived Therapeutics Status and Prospect (2014-2025)
1.4.7 Southeast Asia Human Plasma-Derived Therapeutics Status and Prospect (2014-2025)
1.4.8 India Human Plasma-Derived Therapeutics Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Human Plasma-Derived Therapeutics
2.3 Manufacturing Process Analysis of Human Plasma-Derived Therapeutics
2.4 Industry Chain Structure of Human Plasma-Derived Therapeutics
3 Development and Manufacturing Plants Analysis of Human Plasma-Derived Therapeutics
3.1 Capacity and Commercial Production Date
3.2 Global Human Plasma-Derived Therapeutics Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Human Plasma-Derived Therapeutics
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Human Plasma-Derived Therapeutics Production and Capacity Analysis
4.2 Human Plasma-Derived Therapeutics Revenue Analysis
4.3 Human Plasma-Derived Therapeutics Price Analysis
4.4 Market Concentration Degree
5 Human Plasma-Derived Therapeutics Regional Market Analysis
5.1 Human Plasma-Derived Therapeutics Production by Regions
5.1.1 Global Human Plasma-Derived Therapeutics Production by Regions
5.1.2 Global Human Plasma-Derived Therapeutics Revenue by Regions
5.2 Human Plasma-Derived Therapeutics Consumption by Regions
5.3 North America Human Plasma-Derived Therapeutics Market Analysis
5.3.1 North America Human Plasma-Derived Therapeutics Production
5.3.2 North America Human Plasma-Derived Therapeutics Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Human Plasma-Derived Therapeutics Import and Export
5.4 Europe Human Plasma-Derived Therapeutics Market Analysis
5.4.1 Europe Human Plasma-Derived Therapeutics Production
5.4.2 Europe Human Plasma-Derived Therapeutics Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Human Plasma-Derived Therapeutics Import and Export
5.5 China Human Plasma-Derived Therapeutics Market Analysis
5.5.1 China Human Plasma-Derived Therapeutics Production
5.5.2 China Human Plasma-Derived Therapeutics Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Human Plasma-Derived Therapeutics Import and Export
5.6 Japan Human Plasma-Derived Therapeutics Market Analysis
5.6.1 Japan Human Plasma-Derived Therapeutics Production
5.6.2 Japan Human Plasma-Derived Therapeutics Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Human Plasma-Derived Therapeutics Import and Export
5.7 Southeast Asia Human Plasma-Derived Therapeutics Market Analysis
5.7.1 Southeast Asia Human Plasma-Derived Therapeutics Production
5.7.2 Southeast Asia Human Plasma-Derived Therapeutics Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Human Plasma-Derived Therapeutics Import and Export
5.8 India Human Plasma-Derived Therapeutics Market Analysis
5.8.1 India Human Plasma-Derived Therapeutics Production
5.8.2 India Human Plasma-Derived Therapeutics Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Human Plasma-Derived Therapeutics Import and Export
6 Human Plasma-Derived Therapeutics Segment Market Analysis (by Type)
6.1 Global Human Plasma-Derived Therapeutics Production by Type
6.2 Global Human Plasma-Derived Therapeutics Revenue by Type
6.3 Human Plasma-Derived Therapeutics Price by Type
7 Human Plasma-Derived Therapeutics Segment Market Analysis (by Application)
7.1 Global Human Plasma-Derived Therapeutics Consumption by Application
7.2 Global Human Plasma-Derived Therapeutics Consumption Market Share by Application (2014-2019)
8 Human Plasma-Derived Therapeutics Major Manufacturers Analysis
8.1 Alkahest
8.1.1 Alkahest Human Plasma-Derived Therapeutics Production Sites and Area Served
8.1.2 Alkahest Product Introduction, Application and Specification
8.1.3 Alkahest Human Plasma-Derived Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Baxter
8.2.1 Baxter Human Plasma-Derived Therapeutics Production Sites and Area Served
8.2.2 Baxter Product Introduction, Application and Specification
8.2.3 Baxter Human Plasma-Derived Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 CSL Behring
8.3.1 CSL Behring Human Plasma-Derived Therapeutics Production Sites and Area Served
8.3.2 CSL Behring Product Introduction, Application and Specification
8.3.3 CSL Behring Human Plasma-Derived Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Entegrion, Inc.
8.4.1 Entegrion, Inc. Human Plasma-Derived Therapeutics Production Sites and Area Served
8.4.2 Entegrion, Inc. Product Introduction, Application and Specification
8.4.3 Entegrion, Inc. Human Plasma-Derived Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Gammagard
8.5.1 Gammagard Human Plasma-Derived Therapeutics Production Sites and Area Served
8.5.2 Gammagard Product Introduction, Application and Specification
8.5.3 Gammagard Human Plasma-Derived Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Grifols
8.6.1 Grifols Human Plasma-Derived Therapeutics Production Sites and Area Served
8.6.2 Grifols Product Introduction, Application and Specification
8.6.3 Grifols Human Plasma-Derived Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Kedrion
8.7.1 Kedrion Human Plasma-Derived Therapeutics Production Sites and Area Served
8.7.2 Kedrion Product Introduction, Application and Specification
8.7.3 Kedrion Human Plasma-Derived Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Octapharma
8.8.1 Octapharma Human Plasma-Derived Therapeutics Production Sites and Area Served
8.8.2 Octapharma Product Introduction, Application and Specification
8.8.3 Octapharma Human Plasma-Derived Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Prometic Life Sciences
8.9.1 Prometic Life Sciences Human Plasma-Derived Therapeutics Production Sites and Area Served
8.9.2 Prometic Life Sciences Product Introduction, Application and Specification
8.9.3 Prometic Life Sciences Human Plasma-Derived Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Sanquin
8.10.1 Sanquin Human Plasma-Derived Therapeutics Production Sites and Area Served
8.10.2 Sanquin Product Introduction, Application and Specification
8.10.3 Sanquin Human Plasma-Derived Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Shire
9 Development Trend of Analysis of Human Plasma-Derived Therapeutics Market
9.1 Global Human Plasma-Derived Therapeutics Market Trend Analysis
9.1.1 Global Human Plasma-Derived Therapeutics Market Size (Volume and Value) Forecast 2019-2025
9.2 Human Plasma-Derived Therapeutics Regional Market Trend
9.2.1 North America Human Plasma-Derived Therapeutics Forecast 2019-2025
9.2.2 Europe Human Plasma-Derived Therapeutics Forecast 2019-2025
9.2.3 China Human Plasma-Derived Therapeutics Forecast 2019-2025
9.2.4 Japan Human Plasma-Derived Therapeutics Forecast 2019-2025
9.2.5 Southeast Asia Human Plasma-Derived Therapeutics Forecast 2019-2025
9.2.6 India Human Plasma-Derived Therapeutics Forecast 2019-2025
9.3 Human Plasma-Derived Therapeutics Market Trend (Product Type)
9.4 Human Plasma-Derived Therapeutics Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Human Plasma-Derived Therapeutics Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Human Plasma-Derived Therapeutics
Table Global Human Plasma-Derived Therapeutics Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Human Plasma-Derived Therapeutics Production Market Share by Types in 2018
Figure Albumin Product Picture
Figure Immunoglobulin Product Picture
Figure Clotting Factor Product Picture
Figure Prothrombin Complex Product Picture
Figure Others Product Picture
Table Global Human Plasma-Derived Therapeutics Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Human Plasma-Derived Therapeutics Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Research Center
Figure Global Human Plasma-Derived Therapeutics Revenue (Million USD) (2014-2025)
Figure Global Human Plasma-Derived Therapeutics Production (K Pcs) (2014-2025)
Figure North America Human Plasma-Derived Therapeutics Market Size (Million USD) (2014-2025)
Figure Europe Human Plasma-Derived Therapeutics Market Size (Million USD) (2014-2025)
Figure China Human Plasma-Derived Therapeutics Market Size (Million USD) (2014-2025)
Figure Japan Human Plasma-Derived Therapeutics Market Size (Million USD) (2014-2025)
Figure Southeast Asia Human Plasma-Derived Therapeutics Market Size (Million USD) (2014-2025)
Figure India Human Plasma-Derived Therapeutics Market Size (Million USD) (2014-2025)
Table Human Plasma-Derived Therapeutics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Human Plasma-Derived Therapeutics in 2018
Figure Manufacturing Process Analysis of Human Plasma-Derived Therapeutics
Figure Industry Chain Structure of Human Plasma-Derived Therapeutics
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Human Plasma-Derived Therapeutics Manufacturing Plants Distribution
Table Human Plasma-Derived Therapeutics Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Human Plasma-Derived Therapeutics Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Human Plasma-Derived Therapeutics Production (K Pcs) of Major Manufacturers (2014-2019)
Table Human Plasma-Derived Therapeutics Production Market Share of Major Manufacturers (2014-2019)
Figure Human Plasma-Derived Therapeutics Production Share by Manufacturers in 2018
Table Human Plasma-Derived Therapeutics Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Human Plasma-Derived Therapeutics Revenue Market Share of Major Manufacturers (2014-2019)
Figure Human Plasma-Derived Therapeutics Revenue Share by Manufacturers in 2018
Table Human Plasma-Derived Therapeutics Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Human Plasma-Derived Therapeutics Production by Regions 2014-2019 (K Pcs)
Table Global Human Plasma-Derived Therapeutics Production Market Share by Regions 2014-2019
Figure Global Human Plasma-Derived Therapeutics Production Market Share by Regions in 2018
Table Global Human Plasma-Derived Therapeutics Revenue by Regions 2014-2019 (Million USD)
Table Global Human Plasma-Derived Therapeutics Revenue Market Share by Regions 2014-2019
Figure Global Human Plasma-Derived Therapeutics Revenue Market Share by Regions in 2018
Table Global Human Plasma-Derived Therapeutics Consumption by Regions 2014-2019 (K Pcs)
Table Global Human Plasma-Derived Therapeutics Consumption Market Share by Regions 2014-2019
Figure North America Human Plasma-Derived Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure North America Human Plasma-Derived Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table North America Human Plasma-Derived Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Europe Human Plasma-Derived Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Human Plasma-Derived Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Human Plasma-Derived Therapeutics Production, Consumption Import and Export (K Pcs)
Figure China Human Plasma-Derived Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure China Human Plasma-Derived Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table China Human Plasma-Derived Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Japan Human Plasma-Derived Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Human Plasma-Derived Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Human Plasma-Derived Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Human Plasma-Derived Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Human Plasma-Derived Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Human Plasma-Derived Therapeutics Production, Consumption Import and Export (K Pcs)
Figure India Human Plasma-Derived Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure India Human Plasma-Derived Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table India Human Plasma-Derived Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Human Plasma-Derived Therapeutics Market Share by Application (2014-2019)
Figure Global Value (Consumption) Human Plasma-Derived Therapeutics Market Share by Application (2014-2019)
Table Alkahest Human Plasma-Derived Therapeutics Production Sites and Area Served
Table Alkahest Human Plasma-Derived Therapeutics Product Introduction, Application and Specification
Table Alkahest Human Plasma-Derived Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Alkahest Human Plasma-Derived Therapeutics Production Growth Rate (2014-2019)
Table Alkahest Human Plasma-Derived Therapeutics Production Market Share (2014-2019)
Figure Alkahest Human Plasma-Derived Therapeutics Revenue Market Share (2014-2019)
Table Alkahest Human Plasma-Derived Therapeutics Main Business and Markets Served
Table Baxter Human Plasma-Derived Therapeutics Production Sites and Area Served
Table Baxter Human Plasma-Derived Therapeutics Product Introduction, Application and Specification
Table Baxter Human Plasma-Derived Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Baxter Human Plasma-Derived Therapeutics Production Growth Rate (2014-2019)
Table Baxter Human Plasma-Derived Therapeutics Production Market Share (2014-2019)
Figure Baxter Human Plasma-Derived Therapeutics Revenue Market Share (2014-2019)
Table Baxter Human Plasma-Derived Therapeutics Main Business and Markets Served
Table CSL Behring Human Plasma-Derived Therapeutics Production Sites and Area Served
Table CSL Behring Human Plasma-Derived Therapeutics Product Introduction, Application and Specification
Table CSL Behring Human Plasma-Derived Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table CSL Behring Human Plasma-Derived Therapeutics Production Growth Rate (2014-2019)
Table CSL Behring Human Plasma-Derived Therapeutics Production Market Share (2014-2019)
Figure CSL Behring Human Plasma-Derived Therapeutics Revenue Market Share (2014-2019)
Table CSL Behring Human Plasma-Derived Therapeutics Main Business and Markets Served
Table Entegrion, Inc. Human Plasma-Derived Therapeutics Production Sites and Area Served
Table Entegrion, Inc. Human Plasma-Derived Therapeutics Product Introduction, Application and Specification
Table Entegrion, Inc. Human Plasma-Derived Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Entegrion, Inc. Human Plasma-Derived Therapeutics Production Growth Rate (2014-2019)
Table Entegrion, Inc. Human Plasma-Derived Therapeutics Production Market Share (2014-2019)
Figure Entegrion, Inc. Human Plasma-Derived Therapeutics Revenue Market Share (2014-2019)
Table Entegrion, Inc. Human Plasma-Derived Therapeutics Main Business and Markets Served
Table Gammagard Human Plasma-Derived Therapeutics Production Sites and Area Served
Table Gammagard Human Plasma-Derived Therapeutics Product Introduction, Application and Specification
Table Gammagard Human Plasma-Derived Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Gammagard Human Plasma-Derived Therapeutics Production Growth Rate (2014-2019)
Table Gammagard Human Plasma-Derived Therapeutics Production Market Share (2014-2019)
Figure Gammagard Human Plasma-Derived Therapeutics Revenue Market Share (2014-2019)
Table Gammagard Human Plasma-Derived Therapeutics Main Business and Markets Served
Table Grifols Human Plasma-Derived Therapeutics Production Sites and Area Served
Table Grifols Human Plasma-Derived Therapeutics Product Introduction, Application and Specification
Table Grifols Human Plasma-Derived Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Grifols Human Plasma-Derived Therapeutics Production Growth Rate (2014-2019)
Table Grifols Human Plasma-Derived Therapeutics Production Market Share (2014-2019)
Figure Grifols Human Plasma-Derived Therapeutics Revenue Market Share (2014-2019)
Table Grifols Human Plasma-Derived Therapeutics Main Business and Markets Served
Table Kedrion Human Plasma-Derived Therapeutics Production Sites and Area Served
Table Kedrion Human Plasma-Derived Therapeutics Product Introduction, Application and Specification
Table Kedrion Human Plasma-Derived Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Kedrion Human Plasma-Derived Therapeutics Production Growth Rate (2014-2019)
Table Kedrion Human Plasma-Derived Therapeutics Production Market Share (2014-2019)
Figure Kedrion Human Plasma-Derived Therapeutics Revenue Market Share (2014-2019)
Table Kedrion Human Plasma-Derived Therapeutics Main Business and Markets Served
Table Octapharma Human Plasma-Derived Therapeutics Production Sites and Area Served
Table Octapharma Human Plasma-Derived Therapeutics Product Introduction, Application and Specification
Table Octapharma Human Plasma-Derived Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Octapharma Human Plasma-Derived Therapeutics Production Growth Rate (2014-2019)
Table Octapharma Human Plasma-Derived Therapeutics Production Market Share (2014-2019)
Figure Octapharma Human Plasma-Derived Therapeutics Revenue Market Share (2014-2019)
Table Octapharma Human Plasma-Derived Therapeutics Main Business and Markets Served
Table Prometic Life Sciences Human Plasma-Derived Therapeutics Production Sites and Area Served
Table Prometic Life Sciences Human Plasma-Derived Therapeutics Product Introduction, Application and Specification
Table Prometic Life Sciences Human Plasma-Derived Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Prometic Life Sciences Human Plasma-Derived Therapeutics Production Growth Rate (2014-2019)
Table Prometic Life Sciences Human Plasma-Derived Therapeutics Production Market Share (2014-2019)
Figure Prometic Life Sciences Human Plasma-Derived Therapeutics Revenue Market Share (2014-2019)
Table Prometic Life Sciences Human Plasma-Derived Therapeutics Main Business and Markets Served
Table Sanquin Human Plasma-Derived Therapeutics Production Sites and Area Served
Table Sanquin Human Plasma-Derived Therapeutics Product Introduction, Application and Specification
Table Sanquin Human Plasma-Derived Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Sanquin Human Plasma-Derived Therapeutics Production Growth Rate (2014-2019)
Table Sanquin Human Plasma-Derived Therapeutics Production Market Share (2014-2019)
Figure Sanquin Human Plasma-Derived Therapeutics Revenue Market Share (2014-2019)
Table Sanquin Human Plasma-Derived Therapeutics Main Business and Markets Served
Table Shire Human Plasma-Derived Therapeutics Production Sites and Area Served
Figure Global Human Plasma-Derived Therapeutics Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Human Plasma-Derived Therapeutics Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Human Plasma-Derived Therapeutics Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Human Plasma-Derived Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Human Plasma-Derived Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Human Plasma-Derived Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Human Plasma-Derived Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Human Plasma-Derived Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Human Plasma-Derived Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Human Plasma-Derived Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Human Plasma-Derived Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Human Plasma-Derived Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Human Plasma-Derived Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Human Plasma-Derived Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Human Plasma-Derived Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Human Plasma-Derived Therapeutics by Type (2019-2025)
Table Global Consumption (K Pcs) of Human Plasma-Derived Therapeutics by Application (2019-2025)
Table Human Plasma-Derived Therapeutics Distributors List
Table Human Plasma-Derived Therapeutics Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
ヒトパピロマビル治療薬のグローバル市場調査 2019年 The global Human Papillomaviru Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Human Papillomaviru Therapeutics volume and value at global level, regional level and company level. From …- ヒト血清アルブミンのグローバル市場調査 2019年 The global Human Serum Albumin market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Human Serum Albumin volume and value at global level, regional level and company level. From a global perspective, this…
- グリア細胞株由来神経栄養因子のグローバル市場調査 2019年 The global Glial Cell Line Derived Neurotrophic Factor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Glial Cell Line Derived Neurotrophic Factor volume and value at global level, regional level an…
- 世界及び中国のグリア細胞由来神経栄養因子市場2018 The 'Global and Chinese Glial Cell Line Derived Neurotrophic Factor Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Glial Cell Line Derived Neurotrophic Factor industry with a focus on the Chinese market. The report provides key sta…
- ヒトプロトロンビン複合体の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available. Scope of the Report: This repor…